Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 6/20 | 0.56 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.53 |
| ▸ | AR | P10275 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5211247 | 0.87 | AR (0.54) | SRD5A2SRD5A1AR | |
| SCHEMBL5248685 | 0.84 | AR (0.53) | SRD5A2SRD5A1AR | |
| SCHEMBL9022160 | 0.83 | SRD5A2 (0.52) | SRD5A2SRD5A1 | |
| SCHEMBL7080627 | 0.82 | SRD5A1 (0.65) | SRD5A2SRD5A1AR | |
| SCHEMBL5214662 | 0.82 | SRD5A1 (0.65) | SRD5A2SRD5A1AR | |
| SCHEMBL8892698 | 0.79 | AR (0.51) | SRD5A2SRD5A1AR | |
| SCHEMBL5212304 | 0.79 | SRD5A1 (0.66) | SRD5A2SRD5A1AR | |
| SCHEMBL5212317 | 0.79 | SRD5A1 (0.66) | SRD5A2SRD5A1AR | |
| SCHEMBL8895980 | 0.78 | SRD5A1 (0.49) | SRD5A2SRD5A1AR | |
| SCHEMBL9116041 | 0.78 | AR (0.51) | SRD5A2SRD5A1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0484094-B1 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO CO (JP) | 1996-06-26 | — | — | EP | claimed |
| US-5302621-A | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1994-04-12 | — | — | US | claimed |
| EP-0484094-A2 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | Sankyo Company Limited (JP) | 1992-05-06 | — | — | EP | claimed |
| EP-0484094-B1 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO CO (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-5302621-A | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1994-04-12 | — | — | US | disclosed |
| EP-0484094-A2 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | Sankyo Company Limited (JP) | 1992-05-06 | — | — | EP | disclosed |